Seres Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in development and research of some of their therapies.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“The strains included in SER-262 were selected based on multiple criteria including analysis of human microbiome data, efficacy in animal models of CDI, and bacterial strain level characterization.” Read the following article
Seres Therapeutics, Inc. is a microbiome therapeutics platform company, which engages in developing biological drugs. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. [Source: MarketWatch]
Company Website: http://www.serestherapeutics.com